Collectively, these data indicate that MYSM1 expression in CRPC cells results in the suppression of androgen-independent growth and induction of cell cycle arrest as well as cellular senescence, suggesting a tumor-suppressive role of MYSM1 in CRPC cells. Here, MYSM1 is linked to neoplasm.